Neurocrine Biosciences (NBIX) EBT Margin (2010 - 2026)
Neurocrine Biosciences (NBIX) posted EBT Margin of 16.91% for Q2 2026, down 6.29 percentage points from 23.20% a year earlier and down 13.39 percentage points from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) EBT Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Neurocrine Biosciences was 27.87%, up 6.87 percentage points year-over-year; for FY2025, it came in at 24.66%, up 4.03 percentage points from FY2024.
- Annual EBT Margin has increased for four consecutive years, with a five-year change of +14.46 percentage points (FY2020 to FY2025).
- In prior years, Neurocrine Biosciences' EBT Margin was 20.63% in FY2024 (+3.04 pp), 17.60% in FY2023 (+3.23 pp), 14.37% in FY2022 (+5.42 pp) and 8.95% in FY2021 (-1.26 pp).
- The Q2 2026 figure stands as the lowest quarterly EBT Margin since Q1 2025.
- On a year-over-year basis, EBT Margin increased in five of the last eight quarters, with an average year-over-year change of +3.57 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q4 2022, with a gain of 33.04 percentage points; the weakest was Q1 2023, with a drop of 31.46 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was 30.30% (Q1 2026), 29.72% (Q4 2025) and 36.71% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 16.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.91% |
| Mar 31, 2026 | 30.30% |
| Dec 31, 2025 | 29.72% |
| Sep 30, 2025 | 36.71% |
| Jun 30, 2025 | 23.20% |
| Mar 31, 2025 | 2.57% |
| Dec 31, 2024 | 25.90% |
| Sep 30, 2024 | 30.59% |
| Jun 30, 2024 | 16.71% |
| Mar 31, 2024 | 6.70% |
| Dec 31, 2023 | 38.47% |
| Sep 30, 2023 | 23.18% |
| Jun 30, 2023 | 26.86% |
| Mar 31, 2023 | -24.57% |
| Dec 31, 2022 | 28.62% |
| Sep 30, 2022 | 25.24% |
| Jun 30, 2022 | -6.16% |
| Mar 31, 2022 | 6.89% |
| Dec 31, 2021 | -4.42% |
| Sep 30, 2021 | 10.30% |
API Access
Neurocrine Biosciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();